Article info
Commentary
About antifragility and the challenge of dealing with endovascular therapy trials that fail to show a positive result
- Correspondence to Dr Mayank Goyal, Diagnostic Imaging, University of Calgary, Calgary, AB T2N2T9, Canada; mgoyal{at}ucalgary.ca
Citation
About antifragility and the challenge of dealing with endovascular therapy trials that fail to show a positive result
Publication history
- Accepted November 19, 2019
- First published December 10, 2019.
Online issue publication
March 17, 2021
Article Versions
- Previous version (18 February 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.